Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05473975
Other study ID # MOA_2022_3
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 24, 2023
Est. completion date July 23, 2025

Study information

Verified date November 2023
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact Amélie YAVCHITZ
Phone 01 48 03 64 54
Email ayavhitz@for.paris
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Early recanalization is a major prognostic factor in vascular accidents ischemic brain injury (AIC). The acute phase therapies of AIC aim to recanalization by intravenous thrombolysis and/or mechanical thrombectomy. Recanalization is identified immediately during thrombectomy by per-procedural arteriography. For the thrombolysis, only a performed MRI will validate the recanalization. This "proof of concept" study aims to identify an Electro-Encephalographic biomarker (EEG) of the recanalization in real time, the EEG being easy to set up. This biomarker will be sought during recanalization certified by thrombectomy in order to identify the window time for which the biomarker must be sought on the EEG. During this study, the identified EEG biomarker can be used to validate the recanalization during the intravenous thrombolysis in future studies


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date July 23, 2025
Est. primary completion date January 23, 2025
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient over 18 years old - Presenting a cerebral infarction with proximal occlusion of the sylvian artery requiring thrombectomy - No objection to participation in the study Exclusion Criteria: - Pregnant or breastfeeding women - Patient benefiting from legal protection - Absence of affiliation to a social protection scheme - Recent cranial surgery not allowing the installation of a scalp EEG

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Placement of the EGG
Placement of the EGG before the beginning of the thrombectomy

Locations

Country Name City State
France Fondation Ophtalmologique A. de Rothschild Paris

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary IElectro-Encephalographic (EEG) marker of recanalization dentification of an Electro-Encephalographic (EEG) marker of recanalization in patients with cerebral infarction with proximal occlusion of the sylvian artery and recanalized by mechanical thrombectomy inclusion visit
See also
  Status Clinical Trial Phase
Completed NCT05372016 - Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Recruiting NCT05466383 - Screening and Intervention for AIS in Haikou, Hainan Province, China N/A
Completed NCT03676101 - Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 1
Recruiting NCT04895020 - Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years Phase 3
Completed NCT04425291 - Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Completed NCT05496361 - A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke N/A
Completed NCT02905565 - NBP in Adult Patients With Acute Ischemic Stroke (AIS) Phase 2
Recruiting NCT05152329 - Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Idiopathic Scoliosis Among Patients and Caregivers
Terminated NCT05584332 - A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Active, not recruiting NCT06251505 - Cervical Alignment Changes After Correction of Thoracic Adolescent Idiopathic Scoliosis With Thoracic Hypokyphosis
Recruiting NCT04422366 - Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Not yet recruiting NCT03105063 - Evaluation of the AIIS Using Hip Ultrasound(AIISUS) N/A